Cargando…

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives

In recent years, immunotherapy has produced encouraging results in a rapidly increasing number of solid tumors. The responsiveness of bladder cancer to immunotherapy was first established in nonmuscle invasive disease in 1976 with intravesical instillations of bacillus Calmette-Guérin (BCG). Very re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zichi, Clizia, Tucci, Marcello, Leone, Gianmarco, Buttigliero, Consuelo, Vignani, Francesca, Pignataro, Daniele, Scagliotti, Giorgio V., Di Maio, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478823/ https://www.ncbi.nlm.nih.gov/pubmed/28680882 http://dx.doi.org/10.1155/2017/5618174

Ejemplares similares

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
por: Tucci, Marcello, et al.
Publicado: (2018)

Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review
por: Marandino, Laura, et al.
Publicado: (2020)

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside
por: Ungaro, Antonio, et al.
Publicado: (2022)

FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report
por: Zichi, Clizia, et al.
Publicado: (2018)

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment
por: Iuliani, Michele, et al.
Publicado: (2015)

Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer
por: Lo Iacono, Marco, et al.
Publicado: (2016)

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways
por: Bungaro, Maristella, et al.
Publicado: (2020)

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)

Second-line treatment options in hepatocellular carcinoma
por: Marino, Donatella, et al.
Publicado: (2019)

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
por: Audisio, Marco, et al.
Publicado: (2022)

Systemic Immunotherapy for Urothelial Cancer: Current Trends and Future Directions
por: Gupta, Shilpa, et al.
Publicado: (2017)

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives
por: Kitamura, Hiroshi, et al.
Publicado: (2011)

Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
por: Fiorica, Francesco, et al.
Publicado: (2022)

Current Status and Future Perspectives of Immunotherapy for Locally Advanced or Metastatic Urothelial Carcinoma: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Immunotherapy in urothelial carcinoma: fade or future standard?
por: Breyer, Johannes, et al.
Publicado: (2016)

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
por: Aimar, Giacomo, et al.
Publicado: (2021)

Adherence in allergen immunotherapy: Current situation and future implications
por: Gehrt, Francesca, et al.
Publicado: (2022)

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond
por: Audisio, Alessandro, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives
por: Roviello, Giandomenico, et al.
Publicado: (2021)

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
por: Weenink, Bas, et al.
Publicado: (2020)

Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
por: Sener, Ugur, et al.
Publicado: (2022)

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle
por: Berruti, Alfredo, et al.
Publicado: (2010)

Immunotherapy for hepatocellular carcinoma: current status and future perspectives
por: Okusaka, Takuji, et al.
Publicado: (2018)

Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
por: Yang, Minfeng, et al.
Publicado: (2020)

Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives
por: Wołącewicz, Mikołaj, et al.
Publicado: (2020)

Immunotherapy in prostate cancer: current state and future perspectives
por: Handa, Shivani, et al.
Publicado: (2020)

Immunotherapies for pediatric cancer: current landscape and future perspectives
por: Hutzen, Brian, et al.
Publicado: (2019)

Current Status of Immunotherapy for Lung Cancer and Future Perspectives
por: Kim, Ho Cheol, et al.
Publicado: (2020)

Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
por: Lu, Zhihao, et al.
Publicado: (2020)

Immunotherapy in colorectal cancer: current achievements and future perspective
por: Fan, Ahui, et al.
Publicado: (2021)

Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
por: Mandlik, Deepa S, et al.
Publicado: (2023)

Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives
por: Dłubak, Andrzej, et al.
Publicado: (2023)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism
por: Tucci, Francesca, et al.
Publicado: (2023)

Current Perspectives in Cancer Immunotherapy
por: Christofi, Theodoulakis, et al.
Publicado: (2019)

Current landscape and future perspective of sentinel node mapping in endometrial cancer
por: Bogani, Giorgio, et al.
Publicado: (2018)

Current status and future perspectives of immunotherapy in Latin America and Cuba
por: Diaz Rodriguez, Alexander, et al.
Publicado: (2014)

Passive Aβ Immunotherapy: Current Achievements and Future Perspectives
por: Schilling, Stephan, et al.
Publicado: (2018)

Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
por: Voskamp, Marije J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jicqbeapql9u32741errl430og